ANGLE ROTOR COUNTERCURRENT CHROMATOGRAPHY
Filed on 1975-07-22
In recognition of pioneering research and development that has brought NIH technology from the theoretical realms of the laboratory to clinical applications.
Awardee
National Heart Lung and Blood Institute
This development is the first and only FDA approved diagnostic test kit for parvovirus B19. Parvovirus B19 infection in pregnancy is often overlooked simply because most infected pregnant women are asymptomatic or have only mild manifestations, such as slight itching. However, pregnant women (in the first and second trimesters) with the B19 infection can give rise to serious fetal complications during pregnancy. Up to 50% of women are susceptible to parvovirus B19 infection. The B19 infection may result in anemia, pregnancy miscarriage and/or other problems.